E. Diczfalusy — Endo Lab

article 1982

Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate

·doi:10.1016/0010-7824(82)90132-9

The pharmacokinetic and pharmacodynamic effects of vaginal devices releasing levonorgestrel (L-NOG) at a constant rate (in vitro release: approximately 20 micrograms/day) were studied in a group of 20 normally menstruating women during a pe…

article 1981

Pharmacokinetic and pharmacodynamic studies with vaginal devices releasing norethisterone at a constant, near zero order

·doi:10.1016/0010-7824(81)90066-4

article 1979

Biologically active luteinizing hormone (LH) in plasma. V. A re-analysis of the differences in the ratio of biological to immunological LH activities during the menstrual cycle.

The relationship between the biological and immunological activities of human luteinizing hormone (hLH) in plasma collected from female subjects was examined. The biological activity was measured by an in vitro bioassay and the immunologica…

article 1979

Pharmacokinetic and pharmacodynamic effects of small doses of norethisterone released from vaginal rings continuously during 90 days

·doi:10.1016/0010-7824(79)90020-9

article 1972

Radiochemical methods for the assay of α-amylase, glycogen synthetase and phosphorylase in the human endometrium

·doi:10.1016/0010-7824(72)90039-x

article 1951

A Study of the Effect of Intravenous Administration of Progesterone

·doi:10.3109/00016345109154952